We Are Not Promoting Drugs. We Are Promoting Agency.

A viewer accused us of promoting drugs.

Carter answered before I could.

“We’re promoting the use of agency.”

That became the episode.

The GLP-1 argument has become so moralized that we keep missing the market signal underneath it. We were not arguing that the drugs have no risks. We were not arguing that everyone should take them. We were arguing that millions of people have demonstrated a willingness to spend money to change their metabolic health.

That matters because prevention did not have a visible price before.

Now it does.

Once consumers started changing what they ate, drank and bought, other companies had a reason to build for the person trying to stay well. Food companies. Diagnostics companies. Wearables. Life insurers. Fitness platforms. The drug did not finish the job. It revealed the customer.

That is a very different claim from “take the magic pill.”

The deeper conversation was about what happens after demand appears.

I made it personal, as usual.

I have an underactive thyroid. I have nodules that have been biopsied. I take medication and follow a monitoring schedule. The standard model says a primary care physician or endocrinologist “manages” this condition.